Literature DB >> 7514130

Degeneracy of T cell receptor recognition of an influenza virus hemagglutinin epitope restricted by HLA-DQ and -DR class II molecules.

C M Jones1, R A Lake, J R Lamb, A Faith.   

Abstract

DT9301-0229737 the TcR are believed to provide the peptide fragments bound to major histocompatibility (MHC) molecules. TcR have an immunoglobulin (Ig)-like structure and, in an analogous manner to antigen recognition by Ig, the third complementarity determining regions (CDR3) of the TcR are believed to provide the primary contact with the peptide lying in the MHC groove. CDR1 and CDR2 are thought to contact the presenting MHC molecule. We have analyzed seven human CD4+ T cell clones that recognize a conserved peptide epitope (residues 255-270) within the influenza virus hemagglutinin (H3) HA1 subunit. Two T cell clones recognized the peptide in the context of HLA-DRB1*1001 and HLA-DQB1*0602/DQA1*0102, respectively, and shared V alpha, V beta and J beta gene segments. Only the junctional regions encoding the CDR3 regions of the two TcR chains were different. This suggests that the CDR3 regions of these TcR interact with the MHC class II molecule. Six of the T cell clones were restricted by the HLA-DRB1*1001. Two of these T cell clones expressed V beta 9.1 and three expressed V beta 13 gene segments; the remaining clone expressed V beta 7.2, a close homologue of V beta 9.1. A diverse selection of V alpha and J gene segments contributed to the junctional heterogeneity of the TcR, indicating a diversity of sequence combinations recognizing the epitope. Nevertheless, five out of six T cell clones bore a motif in the V alpha CDR3 loop consisting of adjacent acidic and polar amino acid residues, eight residues from the carboxyl end of each CDR3.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7514130     DOI: 10.1002/eji.1830240519

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

1.  HLA-DR1001 presents "altered-self" peptides derived from joint-associated proteins by accepting citrulline in three of its binding pockets.

Authors:  Eddie A James; Antonis K Moustakas; John Bui; George K Papadopoulos; George Bondinas; Jane H Buckner; William W Kwok
Journal:  Arthritis Rheum       Date:  2010-10

2.  Novel promiscuous HLA-DQ HIV Nef peptide that induces IFN-gamma-producing memory CD4+ T cells.

Authors:  V Pancré; B Georges; G Angyalosi; F Castelli; A Delanoye; M Delacre; E Hachulla; B Maillere; A Bouzidi; C Auriault
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

3.  Affinity-matured HLA class II dimers for robust staining of antigen-specific CD4+ T cells.

Authors:  Kenji Sugata; Yukiko Matsunaga; Yuki Yamashita; Munehide Nakatsugawa; Tingxi Guo; Levon Halabelian; Yota Ohashi; Kayoko Saso; Muhammed A Rahman; Mark Anczurowski; Chung-Hsi Wang; Kenji Murata; Hiroshi Saijo; Yuki Kagoya; Dalam Ly; Brian D Burt; Marcus O Butler; Tak W Mak; Naoto Hirano
Journal:  Nat Biotechnol       Date:  2021-03-01       Impact factor: 54.908

4.  Diversity of TCRAV and TCRBV sequences used by human T-cell clones specific for a minimal epitope of Bet v 1, the major birch pollen allergen.

Authors:  H Breiteneder; O Scheiner; R Hajek; W Hulla; R Hüttinger; G Fischer; D Kraft; C Ebner
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

Review 5.  T cell receptor usage in infectious disease.

Authors:  M F Callan; A J McMichael
Journal:  Springer Semin Immunopathol       Date:  1999

6.  Multiplex Identification of Antigen-Specific T Cell Receptors Using a Combination of Immune Assays and Immune Receptor Sequencing.

Authors:  Mark Klinger; Francois Pepin; Jen Wilkins; Thomas Asbury; Tobias Wittkop; Jianbiao Zheng; Martin Moorhead; Malek Faham
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.